000154396 001__ 154396
000154396 005__ 20250318141255.0
000154396 0247_ $$2pmc$$apmc:PMC8121213
000154396 0247_ $$2doi$$a10.1177/1550059420954054
000154396 0247_ $$2pmid$$apmid:32975150
000154396 0247_ $$2ISSN$$a0009-9155
000154396 0247_ $$2ISSN$$a1550-0594
000154396 0247_ $$2ISSN$$a2169-5202
000154396 0247_ $$2altmetric$$aaltmetric:91214460
000154396 037__ $$aDZNE-2021-00249
000154396 041__ $$aEnglish
000154396 082__ $$a610
000154396 1001_ $$aCampanella, Salvatore$$b0
000154396 245__ $$aSpecial Report on the Impact of the COVID-19 Pandemic on Clinical EEG and Research and Consensus Recommendations for the Safe Use of EEG.
000154396 260__ $$aLondon$$bSage$$c2021
000154396 3367_ $$2DRIVER$$aarticle
000154396 3367_ $$2DataCite$$aOutput Types/Journal article
000154396 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1742303534_23995$$xEditorial
000154396 3367_ $$2BibTeX$$aARTICLE
000154396 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000154396 3367_ $$00$$2EndNote$$aJournal Article
000154396 500__ $$aISSN 2169-5202 not unique: **3 hits**.
000154396 520__ $$aThe global COVID-19 pandemic has affected the economy, daily life, and mental/physical health. The latter includes the use of electroencephalography (EEG) in clinical practice and research. We report a survey of the impact of COVID-19 on the use of clinical EEG in practice and research in several countries, and the recommendations of an international panel of experts for the safe application of EEG during and after this pandemic.Fifteen clinicians from 8 different countries and 25 researchers from 13 different countries reported the impact of COVID-19 on their EEG activities, the procedures implemented in response to the COVID-19 pandemic, and precautions planned or already implemented during the reopening of EEG activities.Of the 15 clinical centers responding, 11 reported a total stoppage of all EEG activities, while 4 reduced the number of tests per day. In research settings, all 25 laboratories reported a complete stoppage of activity, with 7 laboratories reopening to some extent since initial closure. In both settings, recommended precautions for restarting or continuing EEG recording included strict hygienic rules, social distance, and assessment for infection symptoms among staff and patients/participants.The COVID-19 pandemic interfered with the use of EEG recordings in clinical practice and even more in clinical research. We suggest updated best practices to allow safe EEG recordings in both research and clinical settings. The continued use of EEG is important in those with psychiatric diseases, particularly in times of social alarm such as the COVID-19 pandemic.
000154396 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000154396 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000154396 650_7 $$2Other$$aCOVID-19
000154396 650_7 $$2Other$$aevent-related oscillations (EROs)
000154396 650_7 $$2Other$$aevent-related potentials (ERPs)
000154396 650_7 $$2Other$$apsychiatry
000154396 650_7 $$2Other$$aquantitative EEG (qEEG)
000154396 650_7 $$2Other$$aresting state electroencephalography (rsEEG)
000154396 650_2 $$2MeSH$$aBrain: physiopathology
000154396 650_2 $$2MeSH$$aBrain Mapping: methods
000154396 650_2 $$2MeSH$$aCOVID-19: physiopathology
000154396 650_2 $$2MeSH$$aCOVID-19: virology
000154396 650_2 $$2MeSH$$aConsensus
000154396 650_2 $$2MeSH$$aElectroencephalography: adverse effects
000154396 650_2 $$2MeSH$$aElectroencephalography: methods
000154396 650_2 $$2MeSH$$aHumans
000154396 650_2 $$2MeSH$$aMental Disorders: physiopathology
000154396 650_2 $$2MeSH$$aSARS-CoV-2: pathogenicity
000154396 7001_ $$aArikan, Kemal$$b1
000154396 7001_ $$aBabiloni, Claudio$$b2
000154396 7001_ $$aBalconi, Michela$$b3
000154396 7001_ $$aBertollo, Maurizio$$b4
000154396 7001_ $$aBetti, Viviana$$b5
000154396 7001_ $$aBianchi, Luigi$$b6
000154396 7001_ $$aBrunovsky, Martin$$b7
000154396 7001_ $$aButtinelli, Carla$$b8
000154396 7001_ $$aComani, Silvia$$b9
000154396 7001_ $$aDi Lorenzo, Giorgio$$b10
000154396 7001_ $$aDumalin, Daniel$$b11
000154396 7001_ $$aEscera, Carles$$b12
000154396 7001_ $$0P:(DE-2719)2811701$$aFallgatter, Andreas$$b13$$udzne
000154396 7001_ $$aFisher, Derek$$b14
000154396 7001_ $$aGiordano, Giulia Maria$$b15
000154396 7001_ $$aGuntekin, Bahar$$b16
000154396 7001_ $$aImperatori, Claudio$$b17
000154396 7001_ $$aIshii, Ryouhei$$b18
000154396 7001_ $$aKajosch, Hendrik$$b19
000154396 7001_ $$aKiang, Michael$$b20
000154396 7001_ $$aLópez-Caneda, Eduardo$$b21
000154396 7001_ $$aMissonnier, Pascal$$b22
000154396 7001_ $$aMucci, Armida$$b23
000154396 7001_ $$aOlbrich, Sebastian$$b24
000154396 7001_ $$aOtte, Georges$$b25
000154396 7001_ $$aPerrottelli, Andrea$$b26
000154396 7001_ $$aPizzuti, Alessandra$$b27
000154396 7001_ $$aPinal, Diego$$b28
000154396 7001_ $$aSalisbury, Dean$$b29
000154396 7001_ $$aTang, Yingying$$b30
000154396 7001_ $$aTisei, Paolo$$b31
000154396 7001_ $$aWang, Jijun$$b32
000154396 7001_ $$aWinkler, Istvan$$b33
000154396 7001_ $$aYuan, Jiajin$$b34
000154396 7001_ $$aPogarell, Oliver$$b35
000154396 773__ $$0PERI:(DE-600)2647038-X$$a10.1177/1550059420954054$$gVol. 52, no. 1, p. 3 - 28$$n1$$p3 - 28$$tClinical EEG and neuroscience$$v52$$x2169-5202$$y2021
000154396 8564_ $$uhttps://pub.dzne.de/record/154396/files/DZNE-2021-00249_Restricted.pdf
000154396 8564_ $$uhttps://pub.dzne.de/record/154396/files/DZNE-2021-00249_Restricted.pdf?subformat=pdfa$$xpdfa
000154396 909CO $$ooai:pub.dzne.de:154396$$pVDB
000154396 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811701$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b13$$kDZNE
000154396 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000154396 9132_ $$0G:(DE-HGF)POF4-899$$1G:(DE-HGF)POF4-890$$2G:(DE-HGF)POF4-800$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000154396 9141_ $$y2021
000154396 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-30
000154396 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-30
000154396 915__ $$0StatID:(DE-HGF)0430$$2StatID$$aNational-Konsortium$$d2022-11-22$$wger
000154396 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-22
000154396 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-22
000154396 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-22
000154396 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2022-11-22
000154396 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-22
000154396 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCLIN EEG NEUROSCI : 2021$$d2022-11-22
000154396 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2022-11-22
000154396 9201_ $$0I:(DE-2719)1240005$$kICRU$$lCore ICRU$$x0
000154396 980__ $$ajournal
000154396 980__ $$aVDB
000154396 980__ $$aI:(DE-2719)1240005
000154396 980__ $$aUNRESTRICTED